Veradermics
MANE
110.95
+1.99
+1.83%
Veradermics
US · MANE
#2148 by market cap
Listed 2026
110.95
+1.99
+1.83%
Live - 5344 symbols - heartbeat 206s ago
· 2026-10-08 07:34
Pre-market
111.21
+0.23%
After-hours
110.95
0.00%
Overnight
110.95
0.00%
- Market cap
- 4.64B
- P/E (TTM)i
- -44.45
- P/Bi
- 5.70
- EPSi
- -2.23
- Div yieldi
- 0.00%
- 52W posi
- 80%
Reader sentiment
Are you bullish or bearish on MANE?
Anonymous reader poll. Unscientific, not investment advice.
About Veradermics
Veradermics, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company was founded in 2019 and is headquartered in New Haven, CT.
- Founded
- 2019
- CEO
- Mr. Reid Alexander Waldman, M.D.
- Employees
- 21
- Headquarters
- New Haven, Connecticut, United States of America
- Fiscal year end
- 12-31
- Website
- veradermics.com
Company profile
- Exchange
- US
- Symbol
- MANE
- Market-cap rank
- #2148
- Listing date
- 2026-02-04
- Market cap
- 4.64B
- Float cap
- 3.58B
- Shares out
- 41.78M
- Float shares
- 32.29M
Sectors & themes
Biotechnology
IPOs
Quote time 2026-10-08 07:34:45 · For reference only, not investment advice and not tailored to your situation.